series-a
Stage
1
Investors
About
Angstrom Bio develops diagnostic technologies by combining amplicon sequencing with machine learning to enhance precision medicine and improve human health outcomes.
Explore Angstrom Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.